Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

ASH 2020

3 - 8 Dec 2020

Online, Virtual, United States of America

ASH 2020: CAR T cell therapy effective as first-line treatment for high-risk large B-cell lymphoma

ASH 2020: CAR T cell therapy effective as first-line treatment for high-risk large B-cell lymphoma

ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia

ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Early phase studies show promise in acute myeloid leukaemia

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued survival benefit

ASH 2020: Follow up data on venetoclax in combination with rituximab or obinutuzumab for CLL shows continued...

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Off-the-shelf immune drug shows promise in aggressive multiple myeloma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

ASH 2020: Study suggests opportunity to personalise immunotherapy for patients with large B cell lymphoma

ASH 2020: Researchers test CRISPR in blood disorders and extend CAR-T therapy to benefit more patients

ASH 2020: Researchers test CRISPR in blood disorders and extend CAR-T therapy to benefit more patients

ASH 2020: Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers

ASH 2020: Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers

ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma

ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma

ASH 2020: Donor stem cell transplant shown to improve survival in older patients with MDS

ASH 2020: Donor stem cell transplant shown to improve survival in older patients with MDS

More from ecancer